Super ARTHGOLD 500mg — Class I drug recall D-1535-2014
Terminated recall by Sung Soo Kim, reported 2014-08-20, distributed nationwide. Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone
| Recall number | D-1535-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sung Soo Kim, La Mirada, CA, United States |
| Recall initiated | 2014-04-15 |
| Classified | 2014-08-08 |
| Reported by FDA | 2014-08-20 |
| Terminated | 2014-09-22 |
| Distributed | Nationwide (US) |
| Countries outside the US | KR |
| Quantity | 6,336 bottles |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00799475353505 |
| Lot numbers | L1P1-6100 |
| Expiration dates | 2016-06-25, 2016-09-16 |
Product
Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement. Manufactured for & Distributed by Nanowellbeing Health, Inc., 14747 Artesia Blvd, #5V, La Mirada, CA 90638. UPC: 7 99475 35350 5.
Reason for recall
Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1535-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.